Clinical Trials at University of Colorado Hospital
As of September 2026, 54 paid clinical trials are recruiting at University of Colorado Hospital, located at 12605 E 16TH AVE, AURORA, CO 80045-2545, phone (720) 848-0000 in Aurora, Colorado. Active studies at this site cover conditions such as Breast Cancer, Obesity and Colorectal Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
54 clinical trials at University of Colorado Hospital
·Clear filters·A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Registry for Stage 2 Type 1 Diabetes
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors
Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial)
Testing the Impact of the MOHR Follow-up Support
CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Losartan + Sunitinib in Treatment of Osteosarcoma
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients
Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.
Platform of Randomized Adaptive Clinical Trials in Critical Illness
Development and Evaluation of a Screening Approach for Sexual Dysfunction in AYA Patients With and Surviving Childhood Cancer
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
Preventing Maternal Mood, Anxiety, and Trauma Symptoms After Cesarean Delivery
Improving Care for Rural Patients With Solid Tumors
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
Study of Placental Function in Healthy and Pathological Pregnancies
Shingrix In Recipients of Allogeneic Transplants
Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia
CC-486 and Venetoclax for Acute Myeloid Leukemia
UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1
Common conditions studied in Aurora
- Breast Cancer (17 active studies)
- Obesity (16 active studies)
- Colorectal Cancer (13 active studies)
- Heart Failure (13 active studies)
- Type 1 Diabetes (11 active studies)
- Melanoma (10 active studies)
Leading research sponsors in Aurora
- University of Colorado, Denver
- VA Office of Research and Development
- National Cancer Institute (NCI)
- Children's Oncology Group
- Merck Sharp & Dohme LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Aurora?
There are approximately 1,053 recruiting clinical trials in Aurora, Colorado listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Aurora pay participants?
Most recruiting trials in Aurora compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Aurora?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Aurora?
The most common conditions under active study in Aurora include Breast Cancer (17), Obesity (16), Colorectal Cancer (13), Heart Failure (13), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Aurora?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Aurora on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Aurora?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Aurora?
Recruiting research sites in Aurora include Children's Hospital Colorado, University of Colorado Anschutz Medical Campus, University of Colorado, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Aurora right now?
The largest active categories in Aurora are Cancer & tumors (286), Diabetes & metabolic (81), Neurology & pain (60). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of University of Colorado Hospital?
University of Colorado Hospital is located at 12605 E 16TH AVE, AURORA, CO 80045-2545. Use the Google Maps link in the intro above to get directions.
How do I contact University of Colorado Hospital?
You can reach University of Colorado Hospital by phone at (720) 848-0000. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.